Skip to main content
. 2020 Sep 23;15(9):e0238698. doi: 10.1371/journal.pone.0238698

Fig 2. The worldwide prevalence between BMPR2 mutation carriers and non-carriers in patients with idiopathic or heritable pulmonary arterial hypertension.

Fig 2

The overall prevalence of BMPR2 mutation carriers in IPAH patients in Korea was 22%, which is higher than in China and lower than in Japan. BMPR2 = bone morphogenetic protein receptor type 2.